Document is current
Any future updates will be listed below
-
Authors
Banerjee, Rahul https://orcid.org/0000-0003-3781-5441
Hosoya, Hitomi
Mikkilineni, Lekha
Hansen, Doris K. https://orcid.org/0000-0002-9813-3578
Wolf, Jeffrey L.
- License Information
-
More Information
Article History
Received: 12 May 2025
Revised: 23 May 2025
Accepted: 17 June 2025
First Online: 30 June 2025
Competing interests
: RB reports consulting: Adaptive Biotech, BMS, Caribou Biosciences, Genentech, Gilead/Kite, GSK, Janssen, Karyopharm, Legend Biotech, Poseida Therapeutics, Pfizer, Sanofi, SparkCures; Research: Abbvie, BMS, Janssen, Novartis, Pack Health, Prothena, Sanofi. LM reports consulting or advisory role for Legend Biotech and BioLineRx. DKH reports consulting: BMS, Janssen, Legend Biotech, Pfizer, Karyopharm, Kite Pharma, AstraZeneca; Research: BMS, Janssen, Kite Pharma, Karyopharm, Adaptive Biotechnologies, and Pentecost Myeloma Research Center. JLW reports consulting: Adaptive. YL reports consulting: Janssen, Legend, Celgene, Sanofi, BMS, Pfizer, Regeneron, Genentech, NexImmune, Caribou; research funding: Janssen, Celgene, BMS. The remaining authors have no conflicts to disclose.
